ftInvstr
DCAL · Healthcare ₹174.0 -1.77% Mkt Cap ₹2722 Cr

DCAL

Healthcare Biotechnology
₹174.0
-1.77% today · 30d -10.6%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for DCAL. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-03-31
REVENUE
₹851 Cr
+18.85% YoY
NET PROFIT
₹22 Cr
-49.55% YoY
OPM
20.67%
-1.51pp YoY
EPS
₹1.39
PE 27.53
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-43.0%, h2=-46.1%, h3=-45.9% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
DCAL27.533.0
BIOCON154.516.88
ANTHEM91.3531.1
ONESOURCE5.79
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
47
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 5
Valuation REASONABLE 60
Growth STRONG 70
Profitability DECENT 52
Technicals WEAK 47
Risk MODERATE 50
Key Stats
TTM PE
27.53
P/B
0.4
52W HIGH
₹321.95
OFF HIGH
-45.95%
MKT CAP
₹2722 Cr
◉ Active Signals
MACDNeutral0.1492
RSI(14)Neutral42.61
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold DCAL and at what entry.

Sign up freeSign in